Skip to main content
. 2025 Apr 5;14(7):2487. doi: 10.3390/jcm14072487
AD Atopic Dermatitis
CT Clinical Trial
DAMD Dupilumab-Associated Mucin Deficiency
DAC Dupilumab-Associated Conjunctivitis
EMA European Medicines Agency
EASI Eczema Area and Severity Index
FDA Food and Drug Administration
IL Interleukin
MUC5AC Mucin 5AC
TBUT Tear Film Break-Up Time
Th2 T-helper 2 cells
RCT Randomized Controlled Trial